UAMY: B.Riley analysts with a buy recommendation and price target

$UAMY

Remember we talked about the only company in the United States that mines antimony?

So we have interesting news!

B.Riley analysts have identified US Antimony Corp as a key player in the US strategic metals market

B.Riley analysts give UAMY stock a "buy" rating and a price target of $3.00! 🔼

And they're not just throwing words around.

Here's what's behind the recommendation:✍️

🔺 A market dominance play: After China - which globally controls antimony exports - announced export restrictions on the critical metal in September 2024, US Antimony found itself in a golden position. 🔝

The company, which owns the only antimony smelter in the US (the Thompson Falls plant in Montana), has become a key and independent supplier - a competitive advantage that cannot be ignored.🚩

🏭 Impressive production capacity - with even greater ambitions: Their smelter is capable of processing 3,840 tons of ore per year, which translates to ~5 million pounds of antimony metal.

But it doesn't stop there - the company plans to double (and even more) its capacity in the medium term. This expansion could position them as a powerful supplier in the domestic market.👑

💪 Stable financial position, ready for growth: With a current ratio of 5.16 (meaning: more than 5 times current assets for every current liability).

The company sits on a strong liquidity base - one that gives it the freedom to finance its ambitious expansion plans without incurring heavy debt.✔️

📈 Growth forecasts: The numbers boosting the stock: B.Riley analysts were not only impressed by the current situation but also anticipate significant earnings expansion: adjusted EBITDA of $56 million in 2026 and $81 million in 2027 💵

A 45% growth in just one year! 💥

With estimated EV/EBITDA multiples of 6.2x and 4.3x respectively, UAMY looks like a particularly cheap asset for the coming years - at least according to analysts.💬

The analysts' big conclusion: 💡 When a company controls a vital asset, while the market faces a global shortage, and simultaneously presents massive growth plans and healthy financial data - it's hard to ignore.

Has B.Riley identified an exceptional opportunity here? What is the reason for their price target - $3.00?

Can they see beyond the fog of Trump's tariffs? 👀

We continue to follow 🔎